A study unveiled that the small molecule inhibitor of IRE1, STF-083010, exhibited significant antimyeloma activity in simulated human multiple myeloma (MM) xenografts, inhibiting IRE1 endonuclease activity both in vitro and in vivo(Papandreou et al. 2011). Here, ERN1 is linked to AL amyloidosis.